Cargando…
Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials
Given the urgent need for coronavirus disease 2019 therapeutics, early in the pandemic the Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership rapidly designed a unique therapeutic agent intake and assessment process for candidate treatment...
Autores principales: | Buchman, Timothy G., Draghia-Akli, Ruxandra, Adam, Stacey J., Aggarwal, Neil R., Fessel, Joshua P., Higgs, Elizabeth S., Menetski, Joseph P., Read, Sarah W., Hughes, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507598/ https://www.ncbi.nlm.nih.gov/pubmed/34495876 http://dx.doi.org/10.1097/CCM.0000000000005295 |
Ejemplares similares
-
Clinical Manifestations of Coronavirus Disease 2019
por: Kutsuna, Satoshi
Publicado: (2021) -
Coronavirus disease 2019 fatigue in the allergy clinic
por: Forester, Joseph P., et al.
Publicado: (2021) -
Clinical Characteristics of Coronavirus Disease 2019 in China
por: Guan, Wei-jie, et al.
Publicado: (2020) -
Clinical Distancing and Mitigation of Coronavirus Disease 2019
por: Scott, Benjamin K., et al.
Publicado: (2020) -
Clinical implications of coronavirus disease 2019 in neonates
por: Kim, Do-Hyun
Publicado: (2021)